Please join us for the global launch of The Lancet Diabetes & Endocrinology Commission on Diagnostic Criteria of Clinical Obesity on 16 January at 1pm - 5pm (GMT).

Endorsed by 75 medical organisations around the world, the Commission sets out a new evidence-based definition of clinical obesity, intended as a chronic, systemic illness directly caused by excess adiposity. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. 

By providing a medically coherent framework for disease diagnosis, the Commission also aims to settle the ongoing dispute around the idea of obesity as a disease, which has been at the centre of one of most controversial and polarising debates in modern medicine.

Agenda

The Commission will present their much anticipated report that sets out a new, clinically relevant diagnosis of obesity.

Commissioners will discuss the implications of their report for practice and policy - with invited experts and other stakeholders joining from London, UK, and other sites across the globe.

A full agenda will be available shortly. 

Registration

Attendance is free but registration is required to receive details of the online platform (Zoom).

A Zoom link will be shared to registrants closer to the event. You will need to use the email you registered with to gain access to the event.

Registration is available on a first-come-first-served basis and a waiting list will be in operation if capacity is exceeded. We recommend that you register as early as possible to secure your online access to the event.

Presentations and discussion will begin from 1pm (GMT) with online platform open from 12:30pm (GMT).

The livestream of the launch is organised in partnership with Metabolic Health Institute.

About The Lancet Diabetes & Endocrinology Commission on Diagnostic Criteria of Clinical Obesity

This Commission has been organised as a partnership between the medical journal The Lancet Diabetes & Endocrinology and King’s Health Partners (KHP) Diabetes, Endocrinology and Obesity.

The Commission involved 56 leading international experts, chaired by Prof Francesco Rubino, Chair of Metabolic and Bariatric Surgery in the Faculty of Life Sciences and Medicine, King's College London, and Honorary Consultant at King's College Hospital NHS Foundation Trust.

Lancet Commissions bring together leading international experts with a broad range of expertise to address the most pressing issues in global health and clinical medicine. Commissions are science-led inquiries aimed at achieving transformational change, and they are especially focused on policy or political action.

The report from the Commission will be published in a future issue of The Lancet Diabetes & Endocrinology. Previously published Lancet Commissions can be viewed at https://www.thelancet.com/commissions.